Gain deep insights into Human Factors Engineering (HFE) and its applications to medical device design by exploring these publications.
Medical device manufacturers who want to stay up to date on the year’s global regulatory developments will appreciate our quarterly regulatory insights.
The medical device regulator in Australia, the Therapeutic Goods Administration (TGA), announced a preview of a new guidance resource for therapeutic goods corrective actions.
The UK medical device regulator, the Medicines and Healthcare products Regulatory Agency (MHRA) finalized the Post-Market Surveillance statutory instrument (PMS SI) in December 2024. Medical device manufacturers doing business in the UK will want to familiarize themselves with this new regulatory requirement to remain compliant and maintain market access.
As the end of the calendar year approaches, Brazil’s National Health Surveillance Agency (ANVISA) has released its database on clinical investigations.
The medical device regulator in Canada, Health Canada (HC), has now made the clinical information provided in support of an application public and it can be accessed via HC’s portal.
In this webinar, our Emergo by UL subject matter expert outlines the latest updates on medical device regulatory requirements in South Korea.
The UK regulator, the Medicines and Healthcare products Regulatory Agency (MHRA), published a revised roadmap outlining the intended timelines for delivering a future regulatory framework for medical devices.
Learn more about the strategies for tackling challenges and boosting submission success for FDA 510(k) predicate selection.